Abstract | BACKGROUND: METHODS: Mice with severe combined immunodeficiency were infected with 107B. microti-infected erythrocytes. Parasites were detected by means of microscopic examination of Giemsa-stained blood smears or nested polymerase chain reaction. CFZ was administered orally. RESULTS: Uninterrupted monotherapy with CFZ curtailed the rise of parasitemia and achieved radical cure. B. microti parasites and B. microti DNA were cleared by days 10 and 50 of therapy, respectively. A 7-day administration of CFZ delayed the rise of parasitemia by 22 days. This rise was caused by B. microti isolates that did not carry mutations in the cytochrome b gene. Accordingly, a 14-day administration of CFZ was sufficient to resolve high-grade parasitemia caused by atovaquone-resistant B. microti parasites. CONCLUSIONS:
Clofazimine is effective against B. microti infection in the immunocompromised host. Additional preclinical studies are required to identify the minimal dose and dosage of CFZ for babesiosis.
|
Authors | Bumduuren Tuvshintulga, Edouard Vannier, Dickson S Tayebwa, Sambuu Gantuya, Thillaiampalam Sivakumar, Azirwan Guswanto, Peter J Krause, Naoaki Yokoyama, Ikuo Igarashi |
Journal | The Journal of infectious diseases
(J Infect Dis)
Vol. 222
Issue 6
Pg. 1027-1036
(08 17 2020)
ISSN: 1537-6613 [Electronic] United States |
PMID | 32310272
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: [email protected]. |
Chemical References |
- DNA, Protozoan
- Leprostatic Agents
- Cytochromes b
- Clofazimine
|
Topics |
- Amino Acid Sequence
- Animals
- Babesia microti
(drug effects, genetics, immunology)
- Babesiosis
(drug therapy, immunology, parasitology)
- Clofazimine
(administration & dosage, adverse effects, therapeutic use)
- Cytochromes b
(chemistry, genetics)
- DNA, Protozoan
- Disease Models, Animal
- Drug Evaluation, Preclinical
- Drug Resistance
- Erythrocytes
(parasitology)
- Immunocompromised Host
- Leprostatic Agents
(administration & dosage, adverse effects, therapeutic use)
- Mice
- Parasitemia
(parasitology)
- Treatment Outcome
|